ACM
CRL icon

Allred Capital Management’s Charles River Laboratories CRL Stock Holding History

Allred Capital Management’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-606
Closed -$224K – 178
2021
Q2 		$224K Sell
606
-75
-11% -$25K 0.11% 167
2021
Q1 		$197K Buy
+681
New +$189K 0.09% 178

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Allred Capital Management's CRL Position: Q3 2021 in Review

Allred Capital Management sold out of Charles River Laboratories (CRL) in Q3 2021, closing a stake of 606 shares — an estimated $224K sold.

Allred Capital Management first reported a position in CRL in Q1 2021 and held it in 2 quarters. The position peaked at $224K in Q2 2021. 676 funds tracked by Wall St. Rank hold CRL as of Q3 2021.

  • Allred Capital Management reported no remaining Charles River Laboratories position as of Q3 2021 after selling out during the quarter.
  • Allred Capital Management sold 606 Charles River Laboratories shares in Q3 2021, an estimated $224K.
  • Allred Capital Management first reported a position in Charles River Laboratories in Q1 2021 and held it in 2 quarters.
  • Allred Capital Management's Charles River Laboratories position peaked at $224K in Q2 2021.
  • 676 funds tracked by Wall St. Rank held Charles River Laboratories as of Q3 2021.

Based on Allred Capital Management's 13F filing for Q3 2021, filed 12 Oct 2021.